The Procter and Gamble Company, Beauty and Grooming - Gillette, Sharon Woods Technical Center, Cincinnati, OH, USA.
Br J Dermatol. 2012 Mar;166 Suppl 1:22-6. doi: 10.1111/j.1365-2133.2011.10786.x.
Individuals with axillary hyperhidrosis have much higher than average sweat rates and are often prescribed anhydrous aluminum chloride (AlCl(3)) solutions. Topical application of these solutions can be irritating to the skin, resulting in poor compliance and lower than desired efficacy.
Demonstrate the efficacy of an over the counter "clinical strength" soft-solid antiperspirant using a night time application regimen and compare to a prescription aluminum chloride (6.5%) antiperspirant using male panelists.
Gravimetric hot room efficacy testing (100 F and 35% Humidity) was performed comparing an over the counter soft-solid antiperspirant to placebo in a single test. Two separate gravimetric tests were placed comparing a prescription aluminum chloride (6.5%) antiperspirant to the same soft solid product using an intent to treat model. Skin irritation was assessed daily by a trained grader.
Placebo testing resulted in 85% of panelists having a reduction in sweating rate greater than 50%. Comparison testing showed the over the counter soft solid reduced sweat rate by an average of 34% better than the prescription product while resulting significantly less skin irritation.
Over the counter "clinical strength" soft-solid antiperspirants can be considered as an alternative treatment to aluminum chloride antiperspirants for the treatment of heavy sweating.
患有腋窝多汗症的个体的出汗率远高于平均水平,通常会被开处方使用无水氯化铝(AlCl(3))溶液。这些溶液的局部应用可能会对皮肤产生刺激性,导致患者顺应性差且疗效低于预期。
使用夜间应用方案展示一种非处方“临床强度”的软固态止汗剂的疗效,并与处方氯化铝(6.5%)止汗剂在男性志愿者中进行比较。
在一项单次测试中,通过重量法热室功效测试(100°F 和 35%湿度),将一种非处方软固态止汗剂与安慰剂进行比较。通过意向治疗模型,进行了两项单独的重量法测试,将处方氯化铝(6.5%)止汗剂与同一软固态产品进行比较。由经过培训的评估员每天评估皮肤刺激情况。
安慰剂测试显示,85%的志愿者的出汗率减少超过 50%。对比测试表明,非处方软固态产品比处方产品平均减少 34%的出汗率,同时皮肤刺激明显减少。
非处方“临床强度”软固态止汗剂可以被视为替代氯化铝止汗剂治疗重度出汗的一种选择。